Ling Geoffrey M.D. 4
4 · CATALYST BIOSCIENCES, INC. · Filed Jan 17, 2020
Insider Transaction Report
Form 4
Ling Geoffrey M.D.
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-01-15+10,000→ 10,000 totalExercise: $7.29Exp: 2030-01-15→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The option shall vest monthly over a period of 36 months commencing January 15, 2020.